Zobrazeno 1 - 10
of 23
pro vyhledávání: '"M. G. Crespo"'
Diet therapy and metabolic control among Chilean adults with a neonatal diagnosis of Phenylketonuria
Autor:
F. Peñaloza, E. Rojas-Agurto, F. Salazar, V. Hamilton, P. Peredo, J. F. Cabello, C. Arias, M. G. Crespo, V. Cornejo, M. J. Leal-Witt
Publikováno v:
Journal of Inborn Errors of Metabolism and Screening, Vol 12 (2024)
Abstract Phenylketonuria (PKU) is an autosomal recessive defect affecting the metabolic pathway of phenylalanine (Phe), causing hyperphenylalaninemia and neurotoxicity. Diagnosis must occur in the neonatal period and treatment should begin as early a
Externí odkaz:
https://doaj.org/article/9b9894df60e64feaa4f71b0babbba23a
Autor:
A Val-Blasco, P Prieto, R I Jaen, M Gil-Fernandez, M Pajares, N Domenech, I Jorge, J Vazquez, A Bueno-Sen, G Ruiz-Hurtado, M G Crespo-Leiro, A Cuadrado, C Delgado, L Bosca, M Fernandez-Velasco
Publikováno v:
European Heart Journal. 42
Background and purpose Myocarditis is a severe inflammatory heart disease and a leading cause of sudden death in young adults; but currently no specific treatment is available. Lipoxins and their derivatives promote the resolution of inflammation con
Autor:
C. A. Isnardi, K. Roberts, R. Quintana, J. Kreimer, C. Echeverria, P. C. Luna, B. M. Virasoro, I. E. Exeni, N. Kogan, M. D. L. A. Correa, D. A. Pereira, D. Zelaya, Y. Tissera, C. Pisoni, M. S. Gálvez Elkin, C. G. Alonso, A. K. Cogo, M. Cosatti, L. Garcia, C. Retamozo, M. Severina, R. Nieto, M. Rosemffet, E. D. Mussano, A. Bertoli, M. Delavega, V. Savio, V. Cosentino, B. Roldan, H. Maldonado Ficco, P. Maid, C. Calle Montoro, L. Fernandez, M. L. Leguizamón, A. B. Gómez Vara, M. A. Alfaro, M. Landi, N. Herscovich, C. Maldini, S. S. De la Vega Fernandez, E. Velozo, P. Giorgis, M. E. Sattler, C. Reyes Gómez, L. Perrotat, C. Reimundes, R. A. Ezquer, V. Saurit, J. Flores Trejo, O. L. Cerda, M. G. Crespo Rocha, V. Carrizo Abarza, I. Strusberg, R. Rojas Tessel, G. Verna, J. M. Bande, P. Farfan, G. Berbotto, G. Pons-Estel, E. E. Schneeberger
Publikováno v:
Annals of the Rheumatic Diseases. 81:1665.2-1666
BackgroundCurrently there is little information on the efficacy and safety of SARS-CoV-2 vaccination in patients with immune-mediated diseases and/or under immunosuppressive treatment in our country, where different types of vaccines and mix regimens
Autor:
C. A. Isnardi, O. L. Cerda, E. E. Schneeberger, M. Landi, C. Calle Montoro, M. A. Alfaro, B. Roldan, A. B. Gómez Vara, P. Giorgis, R. A. Ezquer, M. G. Crespo Rocha, C. Reyes Gómez, M. D. L. A. Correa, M. Rosemffet, V. Carrizo Abarza, S. Catalan Pellet, M. Perandones, C. Reimundes, L. Cruces, L. Yesica, G. Turk, F. Quiroga, N. Laufer, R. Quintana, M. Delavega, P. Maid, G. Pons-Estel, G. Citera
Publikováno v:
Annals of the Rheumatic Diseases. 81:1679.1-1679
BackgroundVaccination for COVID-19 is an essential tool to fight the pandemic. Evidence suggests that patients with immune mediated inflammatory diseases (IMIDs) have less response. The application of a booster shot is a strategy that has been implem
Autor:
M. Cosatti, M. E. D´ Angelo, I. E. Petkovic, M. D. L. A. Correa, D. Zelaya, M. S. Gálvez Elkin, A. K. Cogo, C. Retamozo, R. Nieto, E. D. Mussano, E. M. Cavillon, V. Savio, B. Roldan, P. Maid, L. Fernandez, L. Muñoz, M. L. Leguizamón, N. Herscovich, M. A. Alfaro, C. Maldini, P. Giorgis, C. Reyes Gómez, C. Reimundes, V. Saurit, O. L. Cerda, M. G. Crespo Rocha, I. Strusberg, G. Verna, M. I. Quaglia, E. Picco, S. Catalan Pellet, M. Galan, Z. Troyano, M. Perandones, J. Kreimer, P. C. Luna, C. Echeverria, B. M. Virasoro, K. Roberts, C. A. Isnardi, E. E. Schneeberger, G. Pons-Estel, C. Pisoni
Publikováno v:
Annals of the Rheumatic Diseases. 81:930.2-931
BackgroundPatients with rheumatic diseases (RD) have been excluded from SARS-CoV-2 vaccine trials. Though data appear to show safety and efficacy, mostly evidence remains in mRNA vaccines. However in our country, adenovirus and inactivated vaccines,
Autor:
F, González-Vílchez, J M, Arizón, J, Segovia, L, Almenar, M G, Crespo-Leiro, J, Palomo, J F, Delgado, S, Mirabet, G, Rábago, F, Pérez-Villa, B, Díaz, M L, Sanz, D, Pascual, L, de la Fuente, G, Guinea, Teresa, Blasco
Publikováno v:
TRANSPLANTATION PROCEEDINGS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
RUC. Repositorio da Universidade da Coruña
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
RUC. Repositorio da Universidade da Coruña
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Chronic renal dysfunction (CRD) is a major complication after heart transplantation. We sought to describe the renal function over time, to assess the risk factors associated with CRD development, and to evaluate the clinical attitudes on diagnosis a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::272c1e3460d9772b1db1223d1f8967b0
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1530
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1530
Autor:
E, Roig, L, Almenar, F, González-Vílchez, G, Rábago, J, Delgado, M, Gómez-Bueno, M G, Crespo-Leiro, J M, Arizón, L, de la Fuente, N, Manito, F, Arnal
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 9(6)
Amyloidosis (Am), a systemic disease, has poor prognosis because of organ damage produced by protein deposition in the extracellular space. Although heart transplantation (HTx) is possible, donor availability concerns and high mortality make this app
Publikováno v:
Medicina clinica. 115(6)
This study was conducted to analyze the type, incidence, predisposing factors and prognosis of cutaneous complications (CC) occurring in heart transplant recipients (HTR).A retrospective study was carried out among 192 HTR with a survival1 month. The
Autor:
L, Alonso-Pulpón, L, Almenar, M G, Crespo, L, Silva, J, Segovia, N, Manito, J J, Cuenca, A, Juffé, F, Vallés
Publikováno v:
Revista espanola de cardiologia. 52(10)
Cardiac transplantation is the only therapy that is able to substantially modify the natural evolution of patients with severe heart failure, along with angiotensin converting enzyme inhibitors. Nevertheless, because of the limited number of donors,
Autor:
M G, Crespo-Leiro, A, Ayucar, F, Portela, J J, Cuenca, A, Juffé, L F, Hermida, A, Castro-Beiras
Publikováno v:
The Journal of cardiovascular surgery. 39(2)
We report a case of chylous ascites in a 52-year-old woman after an orthotopic heart transplantation. The patient was successfully managed with conservative treatment including dietetic measures and repeated paracentesis. The potential aetiopathologi